Quick Links
Support Us
The article discusses a recently published paper in the American Journal of Psychiatry titled Predicting Acute Changes in Suicidal Ideation and Planning..
The interview highlights the reciprocal relationship by which mental health affects the likelihood of acquiring HIV infection and how people manage it, while in turn, living with the virus also impacts mental health.
Addressing mental health disparities in urban primary care settings.
Authors: Hong J, Mattingly GW, Carbray JA, Cooper TV, Findling RL, Gignac M, Glaser PE, Lopez FA, Maletic V, McIntyre RS, Robb AS, Singh MK, Stein M, Stahl SM.
Authors: DeDios-Stern, S. L., Gotra, M. Y., Resch, Z. J., Jennette, K. J., Amin-Hanjani, S., Charbel, F. T., Alaraj, A., Testai, F. D., Thulborn, K. R., Vargas, A., Pliskin, N. H., & Soble, J. R. (in press)
The Department of Psychiatry is dedicated to outstanding research, education and service focused on major psychiatric disorders and mental well being. We strive to further new, readily useful knowledge in neuroscience, prevention, and social and clinical areas that will benefit people with mental illnesses, their families and communities. We are committed to UIC's urban mission to provide service, education and research that enhances lives. We deliver the highest quality mental health services with sensitivity and respect to the patient and her/his family. We are dedicated to mental health research to ameliorate illness until cure is found and ultimately to prevent illness and disorder. We are dedicated to instilling in our students and trainees cutting-edge knowledge and skills, respect for patients, and the values of a health professional in a just and humane society.
Welcome to the UIC Department of Psychiatry!
Dr. Tina Grieco-Calub, PhD, at the University of Illinois – Chicago is conducting a research study that is looking at how visual speech cues affect children’s ability to process language. Your child may be eligible if they:
Researchers at the University of Illinois Chicago are studying whether treatment with injectable extended-release naltrexone (XR-NTX; Vivitrol®) and injectable extended-release Buprenorphine (XR-BUP; Sublocade®) is safe and effective for helping people to cut down or stop using cocaine.
Boarded for the last 6 months.
